VeriChip announces exclusive license for patents used in virus triage detection system for H1N1 virus
Tue. September 22, 2009; Posted: 05:07 AM
Sep 22, 2009 (M2 EQUITYBITES via COMTEX) --
CHIP |
Quote |
Chart |
News |
PowerRating -- RFID technology company VeriChip Corporation (Nasdaq:
CHIP |
Quote |
Chart |
News |
PowerRating) and its
development partner, RECEPTORS LLC, announced on Monday that VeriChip
has been granted an exclusive license to RECEPTORS' Patent No.
7,504,364 titled aEUR~Methods of Making Arrays and Artificial Receptors'
and Patent No. 7,469,076 aEUR~Sensors Employing Combinatorial Artificial
Receptors', in its application for the development of the virus triage
detection system for the H1N1 virus.
Financial details of the license were not disclosed.
The virus triage detection system is expected to help process patient
samples.
The patents can also be applied to detection systems for other viruses
and biological threats, such as Methicillin-resistant Staphylococcus
aureus (MRSA).
Comments on this story may be sent to admin@m2.com
For full details on Verichip Corporation (CHIP)
click here. Verichip Corporation (CHIP) has Short Term PowerRatings of 6. Details on Verichip Corporation (CHIP) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index